SCHEMBL7863536

SCHEMBL7863536

[C-]#[N+]c1ccc(Oc2ccc3c(c2)COB3C)c(OCC(=O)OCC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 9/20 0.41
PDE4A P27815 6/20 0.36
PDE4C Q08493 6/20 0.36
PDE4D Q08499 6/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CASP1 P29466 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
POLB P06746 1/20 0.34
PTPN1 P18031 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
NTSR1 P30989 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867407 0.91 PDE4B (0.51) PDE4BPDE4APDE4CPDE4D
SCHEMBL10186842 0.89 PDE4B (0.37) PDE4BPDE4APDE4CPDE4D
SCHEMBL7865812 0.89 PDE4B (0.38) PDE4BPDE4APDE4CPDE4DHSD17B10
SCHEMBL7855772 0.88 PDE4B (0.34) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL7862385 0.88 PDE4B (0.43) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL10186845 0.86 PDE4B (0.36) PDE4BPDE4APDE4CPDE4D
SCHEMBL7861071 0.85 PDE4B (0.42) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL7863028 0.83 SMN1; SMN2 (0.41) ALDH1A1GAAHPGDKDM4ECASP1
SCHEMBL7863839 0.81 GAA (0.49) PDE4BALDH1A1GAAHPGDKDM4E
SCHEMBL10186852 0.81 ALDH1A1 (0.34) PDE4BPDE4APDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039450-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2011-10-18 US disclosed
US-20090291917-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents ANACOR PHARMACEUTICALS, INC. (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291917-A1 Boron-Containing Small Molecules as Anti-Inflammatory Agents NFKBIA, LITAF, CD68 PDE4B 776/4885PDE4A 1019/4885PDE4C 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.